Regeneron is a leading biotechnology company that discovers, develops, and commercializes life-changing medicines for serious diseases across multiple therapeutic areas. With a focus on scientific innovation, Regeneron applies novel technologies to address complex medical challenges, pushing the boundaries of science to improve patient lives. The company is committed to responsible business practices, integrity, and excellence, driving progress in the fight against diseases. From foundational discovery to commercialization, Regeneron's team of scientists, researchers, and medical professionals work together to develop groundbreaking medicines and treatments.